Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
Thu, 09th Jul 2015 09:01
BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.
Read more
(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.
Read more(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.
Read more(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.
Read more(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.
Read more(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.
Read more(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.
Read more(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.
Read more(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.
Read more| Tuesday 19 March | |
| Jarvis Securities PLC | dividend payment date |
| Wednesday 20 March | |
| Virgin Money UK PLC | dividend payment date |
| Thursday 21 March | |
| abrdn Asia Focus PLC | dividend payment date |
| abrdn Private Equity Opportunities Trust PLC | ex-dividend payment date |
| AIB Group PLC | ex-dividend payment date |
| Beazley PLC | ex-dividend payment date |
| BlackRock World Mining Trust PLC | ex-dividend payment date |
| British American Tobacco PLC | ex-dividend payment date |
| Chemring Group PLC | ex-dividend payment date |
| CLS Holdings PLC | ex-dividend payment date |
| Conduit Holdings Ltd | ex-dividend payment date |
| Craneware PLC | ex-dividend payment date |
| Crest Nicholson Holdings PLC | ex-dividend payment date |
| Diverse Income Trust PLC | ex-dividend payment date |
| Fonix Mobile PLC | ex-dividend payment date |
| FW Thorpe PLC | ex-dividend payment date |
| Glanbia PLC | ex-dividend payment date |
| GlobalData PLC | ex-dividend payment date |
| Globalworth Real Estate Investments Ltd | ex-dividend payment date |
| Goodwin PLC | ex-dividend payment date |
| Gore Street Energy Storage Fund PLC | ex-dividend payment date |
| Hargreaves Services PLC | ex-dividend payment date |
| HgCapital Trust PLC | ex-dividend payment date |
| Hikma Pharmaceuticals PLC | ex-dividend payment date |
| Jardine Matheson Holdings LD | ex-dividend payment date |
| London Finance & Investment Group PLC | ex-dividend payment date |
| Maven Income & Growth VCT 3 PLC | ex-dividend payment date |
| Maven Income & Growth VCT 5 PLC | ex-dividend payment date |
| MTI Wireless Edge Ltd | ex-dividend payment date |
| Nichols PLC | ex-dividend payment date |
| NWF Group PLC | ex-dividend payment date |
| Palace Capital PLC | ex-dividend payment date |
| Pearson PLC | ex-dividend payment date |
| Pembroke VCT B PLC | ex-dividend payment date |
| Primorus Investments PLC | ex-dividend payment date |
| Schroders PLC | ex-dividend payment date |
| Triple Point Energy Transition PLC | ex-dividend payment date |
| Tristel PLC | ex-dividend payment date |
| VPC Specialty Lending Investments PLC | dividend payment date |
| Friday 22 March | |
| easyJet PLC | dividend payment date |
| FRP Advisory Group PLC | dividend payment date |
| Gulf Investment Fund PLC | dividend payment date |
| Henderson Opportunities Trust PLC | dividend payment date |
| Hercules Site Services PLC | dividend payment date |
| Impax Asset Management Group PLC | dividend payment date |
| JLEN Environmental Assets Group Ltd | dividend payment date |
| JPMorgan Multi-Asset Growth & Income PLC | dividend payment date |
| Mattioli Woods PLC | dividend payment date |
| Mobeus Income & Growth 2 VCT PLC | dividend payment date |
| Mobeus Income & Growth 4 VCT PLC | dividend payment date |
| Ramsdens Holdings PLC | dividend payment date |
| Riverstone Credit Opportunities Income PLC | dividend payment date |
| Ruffer Investment Co Ltd | dividend payment date |
| Samuel Heath & Sons PLC | dividend payment date |
| Troy Income & Growth Trust PLC | dividend payment date |
| Unilever PLC | dividend payment date |
| Monday 25 March | |
| AstraZeneca PLC | dividend payment date |
| Endeavour Mining PLC | dividend payment date |
| Mountview Estates PLC | dividend payment date |
| Shell PLC | dividend payment date |
| Comments and questions to newsroom@alliancenews.com | |
| A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
| Copyright 2024 Alliance News Ltd. All Rights Reserved. | |
(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.
Read more(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.
Read more(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.
Read more(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.
Read more(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.
Read more
Last checked at